Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Shionogi & Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Summary

Marketlines Shionogi & Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Shionogi & Co., Ltd. since January2007.

Synopsis

Marketlines Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Shionogi & Co., Ltd.s contact information and business Summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Shionogi & Co., Ltd.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Shionogi & Co., Ltd.s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Shionogi & Co., Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Shionogi & Co., Ltd.s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Shionogi & Co., Ltd.s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors business structure and growth strategies.


COMPANY OVERVIEW AND KEY FACTS
--Mergers and Acquisitions - Deal reports
CORPORATE VENTURING
--Corporate Venturing - Overview
--Corporate Venturing - Deal reports
PARTNERSHIP
--Partnership - Overview
--Partnership - Deal reports
DIVESTMENTS
--Divestments - Overview
--Divestments - Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center

List Of Tables



--Shionogi & Co. activity by deal type - volume (2013 -YTD2017)
--Shionogi & Co. legal advisor ranking by value ($m)
--Top Deals(2013 -YTD2017)
--Shionogi & Co. targets and partners (2013 -YTD2017)
--Shionogi & Co. corporate venturing volume and value trend (2013-YTD2017)
--Shionogi & Co. corporate venturing by geography (2013-YTD2017)
--Shionogi & Co. partnership volume and value trend (2013-YTD2017)
--Shionogi & Co. partnership trend by key deal type (2013-YTD2017)
--Shionogi & Co. divestments volume and value trend (2013-YTD2017)
--Shionogi & Co. divestments activity by geography (2013-YTD2017)

List Of Figures



--Shionogi & Co. activity by deal type - volume (2013-YTD2017)
--Shionogi & Co. corporate venturing volume and value trend (2013-YTD2017)
--Shionogi & Co. corporate venturing by geography (2013-YTD2017)
--Shionogi & Co. partnership volume and value trend (2013-YTD2017)
--Shionogi & Co. partnership trend by key deal type (2013-YTD2017)
--Shionogi & Co. divestments volume and value trend (2013-YTD2017)
--Shionogi & Co. divestments by geography (2013-YTD2017)

Shionogi Inc (4507) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Shionogi Inc (Shionogi), formerly Sciele Pharma, Inc., is a pharmaceutical company. It undertakes the development and commercialization of pharmaceutical products to address the unmet medical needs. The company offers a

USD 250 View Report

Shionogi and Co., Ltd. - Strategy, SWOT and Corporate Finance Report

Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance ReportShionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information.

USD 175 View Report

Merck & Co., Inc. - Enterprise Tech Ecosystem Series

Merck & Co., Inc. - Enterprise Tech Ecosystem SeriesMerck & Co Inc. (Merck) is a multinational healthcare company that is engaged in the discovery, development, manufacture, and commercialization of prescription

USD 1495 View Report

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other Companies

Top 20 Vaccine Companies In-depth Analysis 2020: Sanofi, Pfizer, GlaxoSmithKline (GSK), Merck & Co., AstraZeneca, Emergent BioSolutions, Mitsubishi Tanabe Pharma, Seqirus (CSL Limited), Other CompaniesThis report presents an in-depth assessment

USD 1390 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available